Spero Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
SPRO chart
What traders are saying about $SPRO
Latest postsSpero Therapeutics, Inc. news
- Spero Therapeutics, Inc. (SPRO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Spero Therapeutics names regulatory chief, COO to retire
Investing.com ·
- Spero Therapeutics announces key leadership appointments
The Pharmaletter ·
- Spero Therapeutics (NASDAQ:SPRO) Adds Two Leaders as SP001 Development Advances
Kalkine ·
- Spero Therapeutics Appoints Amy Rock and Dae Gon Ha to Leadership Team
citybiz ·
- Spero Therapeutics names two executives, COO to retire
StreetInsider ·
- Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Yahoo Finance ·
- After 11 years, Spero’s COO is set to retire as two executives take new posts.
Stock Titan ·
- Spero Therapeutics (SPRO) Slips to $1.11 as Stock Tests Lower Support Zone - Overvalued Signals
https://www.dars.gov.et/ ·
- Spero Therapeutics Targets 2027 Phase II Launch for SP001 in IgG4-Related Disease
marketbeat.com ·
- Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Yahoo Finance ·
- Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight
Yahoo Finance ·
Spero Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $12.6M | $371,000 | $933,000 | $2.5M |
| Net income | $8.6M | -$68.6M | $22.8M | – |
| Diluted EPS | $0.15 | $-1.27 | $0.43 | $-1.23 |
| Total assets (year end) | $68.9M | $110.5M | $182.4M | $124.8M |
| Cash and equivalents (year end) | $40.3M | $52.9M | $76.3M | $109.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Spero Therapeutics, Inc.
- Ticker
- SPRO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1701108
- Former names
- Spero Therapeutics, LLC
Frequently asked questions
What exchange is Spero Therapeutics, Inc. listed on?
Spero Therapeutics, Inc. trades on the Nasdaq under the ticker symbol SPRO.
What industry is Spero Therapeutics, Inc. in?
Spero Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Spero Therapeutics, Inc. headquartered?
Spero Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Spero Therapeutics, Inc.'s fiscal year end?
Spero Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Spero Therapeutics, Inc. report?
Spero Therapeutics, Inc. reported $12.6M in revenue for calendar year 2025, according to its SEC filings.